Chirag Patel is a Senior Director of Clinical Pharmacology at Bayer Pharmaceuticals, where they lead the clinical pharmacology development strategy for novel immunotherapies aimed at treating hematologic and solid tumors. With over 17 years of experience in clinical drug development, Chirag has been integral to the NDA submission for Onglyza and has contributed to various clinical pharmacology studies. Previously, they served as Associate Director of Clinical Pharmacology at Takeda Pharmaceutical Inc and held roles as Research Investigator and Senior Research Investigator at Bristol-Myers Squibb, where they focused on regulatory communications and designing PK/PD studies. Chirag earned a Ph.D. in Pharmaceutical Sciences from the University of Rhode Island in 2006.
This person is not in the org chart
This person is not in any teams
This person is not in any offices